178 related articles for article (PubMed ID: 15067174)
1. Cox-2 expression in the oxyphilic cells of the normal, hyperplastic, and adenomatous parathyroid gland.
Bell CD; Vidal S; Kovacs K; Anderson J; Rotondo F
Endocr Pathol; 2004; 15(1):29-38. PubMed ID: 15067174
[TBL] [Abstract][Full Text] [Related]
2. Apoptosis and P53, Bcl-2 and Bax gene expression in parathyroid glands of patients with hyperparathyroidism.
Szende B; Farid P; Végso G; Perner F; Kopper L
Pathol Oncol Res; 2004; 10(2):98-103. PubMed ID: 15188026
[TBL] [Abstract][Full Text] [Related]
3. Parathyroid hormone content distinguishes true normal parathyroids from parathyroids of patients with primary hyperparathyroidism.
Weber CJ; Russell J; Chryssochoos JT; Hagler M; McGarity WC
World J Surg; 1996 Oct; 20(8):1010-4; discussion 1014-5. PubMed ID: 8798358
[TBL] [Abstract][Full Text] [Related]
4. Adrenomedullin immunoreactivity tissue distribution in parathyroids of the patients with primary hyperparathyroidism.
Letizia C; Ricci F; De Toma G; Cianci R; Alo P; Celi M; Panzironi G; Mingazzini PL; D'Erasmo E; Mazzuoli GF
Horm Metab Res; 2004 Jul; 36(7):480-4. PubMed ID: 15305232
[TBL] [Abstract][Full Text] [Related]
5. Parathyroid hormone immunohistochemistry in dogs with primary and secondary hyperparathyroidism: the question of adenoma and primary hyperplasia.
van Vonderen IK; Kooistra HS; Peeters ME; Rijnberk A; van den Ingh TS
J Comp Pathol; 2003 Jul; 129(1):61-9. PubMed ID: 12859909
[TBL] [Abstract][Full Text] [Related]
6. Co-expression of parathyroid hormone and chromogranin A in secondary hyperparathyroidism: a functional marker for secretory activity of hyperplastic nodules.
Tanaka R; Umemura S; Kakuta T; Fujisaki T; Sakai H; Saitoh A; Osamura RY
Pathol Res Pract; 2003; 199(2):93-9. PubMed ID: 12747471
[TBL] [Abstract][Full Text] [Related]
7. P53 as a marker of differentiation between hyperplastic and adenomatous parathyroids.
Ricci F; Mingazzini PL; Sebastiani V; D'Erasmo E; Letizia C; De Toma G; Alò PL
Ann Diagn Pathol; 2002 Aug; 6(4):229-35. PubMed ID: 12170454
[TBL] [Abstract][Full Text] [Related]
8. Relationships of parathyroid hormone, parathyroid secretory protein, parathyroid hormone messenger RNA, parathyroid secretory protein mRNA, and replication in human parathyroid adenoma and secondary hyperplasia tissues and cultures.
Weber CJ; Russell J; Costanzo MK; Karp F; Benjamin M; Hardy MA; Feind CR
Surgery; 1992 Dec; 112(6):1089-94; discussion 1094-5. PubMed ID: 1455310
[TBL] [Abstract][Full Text] [Related]
9. Chromogranin A and B in parathyroid tissue of cases of primary hyperparathyroidism: an immunohistochemical study.
Schmid KW; Hittmair A; Ladurner D; Sandbichler P; Gasser R; Tötsch M
Virchows Arch A Pathol Anat Histopathol; 1991; 418(4):295-9. PubMed ID: 2024450
[TBL] [Abstract][Full Text] [Related]
10. Reduced immunostaining for the extracellular Ca2+-sensing receptor in primary and uremic secondary hyperparathyroidism.
Kifor O; Moore FD; Wang P; Goldstein M; Vassilev P; Kifor I; Hebert SC; Brown EM
J Clin Endocrinol Metab; 1996 Apr; 81(4):1598-606. PubMed ID: 8636374
[TBL] [Abstract][Full Text] [Related]
11. Oxyphil Cell Parathyroid Adenomas Causing Primary Hyperparathyroidism: a Clinico-Pathological Correlation.
Howson P; Kruijff S; Aniss A; Pennington T; Gill AJ; Dodds T; Delbridge LW; Sidhu SB; Sywak MS
Endocr Pathol; 2015 Sep; 26(3):250-4. PubMed ID: 26091632
[TBL] [Abstract][Full Text] [Related]
12. Preoperative localization of parathyroid adenomas with technetium-99m methoxyisobutylisonitrile imaging: relationship with P-glycoprotein expression, oxyphilic cell content, and tumoral tissue volume.
Turgut B; Elagoz S; Erselcan T; Koyuncu A; Dokmetas HS; Hasbek Z; Ozdemir S; Aydin C
Cancer Biother Radiopharm; 2006 Dec; 21(6):579-90. PubMed ID: 17257073
[TBL] [Abstract][Full Text] [Related]
13. A study of parathyroid hyperplasia in chronic renal failure.
Yong JL; Vrga L; Warren BA
Pathology; 1994 Apr; 26(2):99-109. PubMed ID: 8090603
[TBL] [Abstract][Full Text] [Related]
14. Analysis of proliferative activity of the parathyroid glands using proliferating cell nuclear antigen in patients with hyperparathyroidism.
Yamaguchi S; Yachiku S; Morikawa M
J Clin Endocrinol Metab; 1997 Aug; 82(8):2681-8. PubMed ID: 9253354
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical expression of Insulin-like growth factor-1, Transforming growth factor-beta1, and Vascular endothelial growth factor in parathyroid adenoma and hyperplasia.
Sayar H; Sahin M; Dogan PO; Karabulut S; Seringec N; Oguz A
Indian J Pathol Microbiol; 2014; 57(4):549-52. PubMed ID: 25308005
[TBL] [Abstract][Full Text] [Related]
16. Flow cytometric DNA analysis of benign hyperfunctioning parathyroid glands: significant difference in the S phase fraction and proliferative index between adenomas and hyperplasias.
Berczi C; Bocsi J; Balázs G; Lukács G
Pathology; 2002 Oct; 34(5):442-5. PubMed ID: 12408343
[TBL] [Abstract][Full Text] [Related]
17. [Study on the cellular proliferation and endocrine activity of the parathyroid gland in hyperparathyroidism].
Hosokawa S
Nihon Hinyokika Gakkai Zasshi; 1993 Aug; 84(8):1424-31. PubMed ID: 8411803
[TBL] [Abstract][Full Text] [Related]
18. Expression of parathyroid hormone-related protein (PTHrP) in parathyroid tissue under normal and pathological conditions.
Kitazawa R; Kitazawa S; Maeda S; Kobayashi A
Histol Histopathol; 2002 Jan; 17(1):179-84. PubMed ID: 11813867
[TBL] [Abstract][Full Text] [Related]
19. Expression of cyclin D1 in parathyroid carcinomas, adenomas, and hyperplasias: a paraffin immunohistochemical study.
Vasef MA; Brynes RK; Sturm M; Bromley C; Robinson RA
Mod Pathol; 1999 Apr; 12(4):412-6. PubMed ID: 10229506
[TBL] [Abstract][Full Text] [Related]
20. Bcl-2, p53 and MIB-1 expression in normal and neoplastic parathyroid tissues.
Naccarato AG; Marcocci C; Miccoli P; Bonadio AG; Cianferotti L; Vignali E; Cipollini G; Viacava P
J Endocrinol Invest; 1998 Mar; 21(3):136-41. PubMed ID: 9591207
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]